抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Elotuzumab
All
TD-HV217016_1.jpg
TD-HV217016_2jpg
TD-HV217016_3.jpg
- Catalog： TD-HV217016
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： BMS-901608,PDL063,HuLuc63,CAS:915296-00-3
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Elotuzumab
| Catalog No. | TD-HV217016 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Humanized |
| Isotype | IgG1-kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | SLAMF7, CRACC, Protein 19A, SLAM family member 7, CD2-like receptor-activating cytotoxic cells, Membrane protein FOAP-12, CD319, Novel Ly9, CD2 subset 1, CS1 |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | Q9NQ25 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | BMS-901608,PDL063,HuLuc63,CAS:915296-00-3 |
| Background | Elotuzumab is a monoclonal antibody directed against the SLAMF7 receptor. Elotuzumab has no significant antimyeloma activity when given as a single agent with relapsed or refractory multiple myeloma (RRMM). Elotuzumab results in improved response and outcome when combined with other antimyeloma agents. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
Detects Human CD319/SLAMF7 in indirect ELISAs. |
|
|
SEC-HPLC detection for Research Grade Elotuzumab. |
|
|
SDS-PAGE for Research Grade Elotuzumab. |